{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:40:19Z","timestamp":1784122819128,"version":"3.55.0"},"reference-count":56,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum show a worse response, which remains largely unexplained. Here, we address the differences among GCTs from two different anatomical locations (testicular versus mediastinal\/extragonadal), with a specific focus on the role of the P53 pathway. It was recently shown that GCTs with TP53 mutations most often localize to the mediastinum. To elucidate the underlying mechanism, TP53 knock-out lines were generated in cisplatin-sensitive and -resistant clones of the representative 2102Ep cell line (wild-type TP53 testicular GCT) and NCCIT cell line (hemizygously mutated TP53, mutant TP53 mediastinal GCT). The full knock-out of TP53 in 2102Ep and resistant NCCIT resulted in an increase in cisplatin resistance, suggesting a contributing role for P53, even in NCCIT, in which P53 had been reported to be non-functional. In conclusion, these results suggest that TP53 mutations contribute to the cisplatin-resistant phenotype of mediastinal GCTs and, therefore, are a potential candidate for targeted treatment. This knowledge provides a novel model system to elucidate the underlying mechanism of clinical behavior and possible alternative treatment of the TP53 mutant and mediastinal GCTs.<\/jats:p>","DOI":"10.3390\/ijms222111774","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T22:21:34Z","timestamp":1635805294000},"page":"11774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1705","authenticated-orcid":false,"given":"Dennis M.","family":"Timmerman","sequence":"first","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Eleveld","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad J. M.","family":"Gillis","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-6329","authenticated-orcid":false,"given":"Carlijn C.","family":"Friedrichs","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-4297","authenticated-orcid":false,"given":"Sanne","family":"Hillenius","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-5679","authenticated-orcid":false,"given":"Tessa L.","family":"Remmers","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Sriram","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert H. J.","family":"Looijenga","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1026","DOI":"10.1016\/j.clgc.2019.06.003","article-title":"Contemporary Incidence and Mortality Rates in Patients with Testicular Germ Cell Tumors","volume":"17","author":"Palumbo","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11912-017-0572-y","article-title":"Current Management of Refractory Germ Cell Tumors and Future Directions","volume":"19","author":"Allen","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer Statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc1568","article-title":"Testicular Germ-Cell Tumours in a Broader Perspective","volume":"5","author":"Oosterhuis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","article-title":"Human Germ Cell Tumours from a Developmental Perspective","volume":"19","author":"Oosterhuis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Timmerman, D., Remmers, T., Hillenius, S., and Looijenga, L. (2021). Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells\u2014Relevance for Understanding (Germ Cell) Tumorigenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105377"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1200\/JCO.2016.68.7798","article-title":"Genetic Determinants of Cisplatin Resistance in Patients with Advanced Germ Cell Tumors","volume":"34","author":"Bagrodia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2002.20.6.1551","article-title":"Role of P53 and MDM2 in Treatment Response of Human Germ Cell Tumors","volume":"20","author":"Kersemaekers","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_11","first-page":"64","article-title":"The Correlation of P53 Protein Expression with Proliferative Activity and Occult Metastases in Clinical Stage I Non-Seminomatous Germ Cell Tumors of the Testis","volume":"7","author":"Ulbright","year":"1994","journal-title":"Mod. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcp.21735","article-title":"Survival Responses of Human Embryonic Stem Cells to DNA Damage","volume":"220","author":"Filion","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gutekunst, M., Oren, M., Weilbacher, A., Dengler, M.A., Markwardt, C., Thomale, J., Aulitzky, W.E., and Van Der Kuip, H. (2011). p53 Hypersensitivity is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019198"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/andr.299","article-title":"Cisplatin Resistance in Germ Cell Tumours: Models and Mechanisms","volume":"3","author":"Jacobsen","year":"2015","journal-title":"Andrology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/andr.12651","article-title":"Germline Genome Protection: Implications for Gamete Quality and Germ Cell Tumorigenesis","volume":"7","author":"Bloom","year":"2019","journal-title":"Andrology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eururo.2009.06.014","article-title":"Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours","volume":"57","author":"Bauer","year":"2010","journal-title":"Eur. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/cddis.2011.33","article-title":"Disruption of the MDM2\u2013p53 Interaction Strongly Potentiates p53-Dependent Apoptosis in Cisplatin-Resistant Human Testicular Carcinoma Cells via the Fas\/FasL Pathway","volume":"2","author":"Koster","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/0008-5472.CAN-12-2876","article-title":"Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4","volume":"73","author":"Gutekunst","year":"2013","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lobo, J., Jer\u00f3nimo, C., and Henrique, R. (2020). Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives. Cancers, 12.","DOI":"10.3390\/cancers12061601"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jcmm.14013","article-title":"Clinical Utility of Plasma miR-371a-3p in Germ Cell Tumors","volume":"23","author":"Mego","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_21","first-page":"4365","article-title":"MDM2\u2019s Social Network","volume":"33","year":"2013","journal-title":"Oncogene"},{"key":"ref_22","first-page":"863","article-title":"Primary Germ Cell Tumor in the Mediastinum-Report of 47 Cases","volume":"28","author":"Zhou","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<592::AID-IJC22>3.0.CO;2-A","article-title":"Lack of Correlation Between Cisplatin-Induced Apoptosis, p53 Status and Expression of Bcl-2 Family Proteins in Testicular Germ Cell Tumour Cell Lines","volume":"73","author":"Burger","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/gcc.20520","article-title":"Further Characterization of the First Seminoma Cell Line TCam-2","volume":"47","author":"Stoop","year":"2008","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/jcp.24994","article-title":"Regulation of MDM2 Stability After DNA Damage","volume":"230","author":"Li","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.1373","article-title":"The Attractive Achilles Heel of Germ Cell Tumours: An Inherent Sensitivity to Apoptosis-Inducing Stimuli","volume":"200","author":"Spierings","year":"2003","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1038\/sj.onc.1208755","article-title":"A p53-Dominant Transcriptional Response to Cisplatin in Testicular Germ Cell Tumor-Derived Human Embyronal Carcinoma","volume":"24","author":"Pike","year":"2005","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85641","DOI":"10.18632\/oncotarget.13063","article-title":"Role of DNA Repair Machinery and P53 in the Testicular Germ Cell Cancer: A Review","volume":"7","author":"Romano","year":"2016","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why are there Hotspot Mutations in the TP53 Gene in Human Cancers?","volume":"25","author":"Baugh","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lobo, J., Gillis, A.J., Berg, A.V.D., Dorssers, L.C.J., Belge, G., Dieckmann, K.-P., Roest, H.P., Van Der Laan, L.J.W., Gietema, J., and Hamilton, R.J. (2019). Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data. Cells, 8.","DOI":"10.3390\/cells8121637"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41585-020-0296-x","article-title":"Application of miRNAs in the Diagnosis and Monitoring of Testicular Germ Cell Tumours","volume":"17","author":"Almstrup","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/bjc.2015.429","article-title":"A pipeline to Quantify Serum and Cerebrospinal Fluid Micrornas for Diagnosis and Detection of Relapse in Paediatric Malignant Germ-Cell Tumours","volume":"114","author":"Murray","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","article-title":"Identification of MicroRNAs from the miR-371\u223c373 and miR-302 Clusters as Potential Serum Biomarkers of Malignant Germ Cell Tumors","volume":"135","author":"Murray","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","article-title":"Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer","volume":"193","author":"Syring","year":"2015","journal-title":"J. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","article-title":"Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review","volume":"80","author":"Albersen","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.biocel.2007.03.022","article-title":"MDM2 and MDM4: p53 Regulators as Targets in Anticancer Therapy","volume":"39","author":"Toledo","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1023\/A:1008333229936","article-title":"Identification of Prognostic Subgroups Among Patients with Metastatic \u2018IGCCCG Poor-Prognosis\u2019 Germ-Cell Cancer: An Explorative Analysis Using Cart Modeling","volume":"11","author":"Kollmannsberger","year":"2000","journal-title":"Ann. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1172\/JCI143884","article-title":"Mediastinal Germ Cell Tumors: Many Questions and Perhaps an Answer","volume":"130","author":"Oosterhuis","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.18632\/oncotarget.1918","article-title":"MDM2 Antagonists Synergize Broadly and Robustly with Compounds Targeting Fundamental Oncogenic Signaling Pathways","volume":"5","author":"Saiki","year":"2014","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8990","DOI":"10.1073\/pnas.1100600108","article-title":"Two-Phase Dynamics of p53 in the DNA Damage Response","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4939-0888-2_3","article-title":"Interplay between the Cell Cycle and Double-Strand Break Response in Mammalian Cells","volume":"1170","author":"Beishline","year":"2014","journal-title":"Cell Cycle Control"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 Induce Apoptosis and how does this Relate to P53-Mediated Tumour Suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_46","first-page":"767","article-title":"Molecular Determinants of Treatment Response in Human Germ Cell Tumors","volume":"9","author":"Mayer","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/bjc.2012.469","article-title":"MicroRNAs miR-371-3 in Serum as Diagnostic Tools in the Management of Testicular Germ Cell Tumours","volume":"107","author":"Dieckmann","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1172\/JCI41939","article-title":"Cytoplasmic p21 Expression Levels Determine Cisplatin Resistance in Human Testicular Cancer","volume":"120","author":"Koster","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ncb3378","article-title":"Chronic p53-Independent p21 Expression Causes Genomic Instability by Deregulating Replication Licensing","volume":"18","author":"Galanos","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","article-title":"p21: A Two-Faced Genome Guardian","volume":"23","author":"Georgakilas","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13059-018-1401-9","article-title":"Mutational Signatures Reveal the role of RAD52 in p53-Independent p21-Driven Genomic Instability","volume":"19","author":"Galanos","year":"2018","journal-title":"Genome Biol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kreis, N.-N., Louwen, F., and Yuan, J. (2019). The Multifaceted p21 (Cip1\/Waf1\/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy. Cancers, 11.","DOI":"10.3390\/cancers11091220"},{"key":"ref_55","first-page":"328","article-title":"Four new human germ cell tumor cell lines","volume":"59","author":"Teshima","year":"1988","journal-title":"Lab. Investig."},{"key":"ref_56","first-page":"796","article-title":"Nonrandom abnormalities in chromosome 1 in human testicular cancers","volume":"40","author":"Wang","year":"1980","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:23:18Z","timestamp":1760167398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":56,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111774"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111774","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]}}}